Archives

  • 2018-07
  • 2018-10
  • 2018-11
  • 2019-04
  • 2019-05
  • 2019-06
  • With this in mind we

    2019-06-11

    With this in mind, we were dismayed that the 133rd session of the WHO Executive Board last year failed to reach consensus on the adoption of a provisional agenda on improving the health and wellbeing of LGBT people. Young people have shown an aptitude for co-operation in improving LGBT health where WHO has so far failed. On March 6, 2014, the International Federation of Medical Students\' Associations (IFMSA), which represents 1·2 million students from 91 member states, reached consensus in support of a sorafenib tosylate on ending discrimination to better the health of LGBT individuals. Endorsed by a two-thirds majority by the IFMSA\'s highest decision-making body, the policy is the first of its kind to recognise the effect of discrimination against LGBT populations on health. With reference to the failures of WHO Executive Board members, the IFMSA policy  calls for improved cooperation from WHO member states, for commitment from health-care providers to adopt a zero-tolerance approach towards discriminatory practices, and for governments to review discriminatory laws that have a detrimental impact on the health of LGBT populations. The sorafenib tosylate document also calls for inclusion of LGBT health in medical curricula.
    Lancet Glob Health —In Immunity in plasmids Comment, the affiliation for Sachiko Ozawa should have been “Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA”. This correction has been made to the online version as of May 22, 2014.